[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979 446 0027", "website": "https://ibioinc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 54, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 753000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 513224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.8, "open": 3.72, "dayLow": 3.06, "dayHigh": 3.8, "regularMarketPreviousClose": 3.8, "regularMarketOpen": 3.72, "regularMarketDayLow": 3.06, "regularMarketDayHigh": 3.8, "payoutRatio": 0.0, "beta": 1.022, "trailingPE": 2.4807692, "forwardPE": -1.9664633, "volume": 778697, "regularMarketVolume": 777596, "averageVolume": 518167, "averageVolume10days": 498440, "averageDailyVolume10Day": 498440, "bid": 3.19, "ask": 3.26, "bidSize": 2, "askSize": 1, "marketCap": 31845842, "fiftyTwoWeekLow": 1.5, "fiftyTwoWeekHigh": 6.89, "priceToSalesTrailing12Months": 84.92225, "fiftyDayAverage": 4.2048, "twoHundredDayAverage": 2.78035, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 29583830, "profitMargins": 0.0, "floatShares": 8599460, "sharesOutstanding": 9874680, "sharesShort": 850923, "sharesShortPriorMonth": 213769, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0862, "heldPercentInsiders": 0.07205, "heldPercentInstitutions": 0.26650998, "shortRatio": 0.9, "shortPercentOfFloat": 0.0863, "impliedSharesOutstanding": 9874680, "bookValue": 1.516, "priceToBook": 2.1273086, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -14234000, "trailingEps": 1.3, "forwardEps": -1.64, "lastSplitFactor": "1:20", "lastSplitDate": 1701216000, "enterpriseToRevenue": 78.89, "enterpriseToEbitda": -2.011, "52WeekChange": 0.4292035, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 3.225, "targetHighPrice": 5.96, "targetLowPrice": 3.6, "targetMeanPrice": 4.78, "targetMedianPrice": 4.78, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 7015000, "totalCashPerShare": 0.71, "ebitda": -14713000, "totalDebt": 4753000, "quickRatio": 1.492, "currentRatio": 1.759, "totalRevenue": 375000, "debtToEquity": 34.207, "revenuePerShare": 0.05, "returnOnAssets": -0.34907, "returnOnEquity": -1.23281, "grossProfits": 375000, "freeCashflow": 4950750, "operatingCashflow": -16092000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -22.095, "financialCurrency": "USD", "symbol": "IBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1743809563, "regularMarketTime": 1743796802, "exchange": "NCM", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -15.13158, "regularMarketPrice": 3.225, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1219152600000, "postMarketChangePercent": 4.80621, "postMarketPrice": 3.38, "postMarketChange": 0.155, "regularMarketChange": -0.57500005, "regularMarketDayRange": "3.06 - 3.8", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 518167, "fiftyTwoWeekLowChange": 1.7249999, "fiftyTwoWeekLowChangePercent": 1.15, "fiftyTwoWeekRange": "1.5 - 6.89", "fiftyTwoWeekHighChange": -3.665, "fiftyTwoWeekHighChangePercent": -0.5319303, "fiftyTwoWeekChangePercent": 42.92035, "dividendDate": 1528675200, "earningsTimestamp": 1739221500, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1.3, "epsForward": -1.64, "epsCurrentYear": -1.59, "priceEpsCurrentYear": -2.0283017, "fiftyDayAverageChange": -0.9798002, "fiftyDayAverageChangePercent": -0.23301946, "twoHundredDayAverageChange": 0.44464993, "twoHundredDayAverageChangePercent": 0.1599259, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "iBio, Inc.", "longName": "iBio, Inc. Common Stock", "displayName": "iBio", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]